References
- Preblud SR. Varicella: complications and costs. Pediatrics 1986; 78(4 Pt 2):728–37
- Seiler HE. A study of herpes zoster particularly in its relationship to chickenpox. J Hygiene 1949; 47:253
- Ross AH. Modification of chickenpox in family contacts by administration of gamma globulin. New Engl J Med 1962; 267:369–76
- Schmader K, George LK, Burchett BM, et al. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995; 171(3):701–4
- Haake DA, Zakowski PC, Haake DL, et al. Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev Infect Dis 1990; 12(5):788–98
- Choo PW, Donahue JG, Manson JE, et al. The epidemiology of varicella and its complications. J Infect Dis 1995; 172(3): 706–12
- Gardner P, Eickhoff T, Poland GA, et al. Adult immunizations. Ann Intern Med 1996; 124(1 Pt l):35–40
- Zimmerman RK. Varicella vaccine: rationale and indications for use. Am Fam Physician 1996; 53(2):647–54
- Straus SE, Ostrove JM, Inchauspe G, et al. Varicella-zoster virus infections: biology, natural history, treatment, and prevention. NIH conference. Ann Intern Med 1988; 108(2):221–37
- American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995; 95(5):791–6
- Wallace MR, Bowler W A, Murray NB, et al. Treatment of adult varicella with oral acyclovir: a randomized, placebo- controlled trial. Ann Intern Med 1992; 117(5):358–63
- Balfour HH Jr, Rotbart HA, Feldman S, et al. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr 1992; 120(4 Pt l):627–33
- Dunkle LM, Arvin AM, Whitley RJ, et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 1991; 325(22):1539–44
- Balfour HH Jr, Kelly JM, Suarez CS, et al. Acyclovir treatment of varicella in otherwise healthy children. J Pediatr 1990; 116(4):633–9
- Brunell PA. Indications for oral acyclovir in children. Pediatr Infect Dis J 1993; 12(11):970
- Whitley RJ. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis 1992; 166(Suppl 1):S51–7
- Whitley RJ, Gnann JW Jr. Acyclovir: a decade later. N Engl J Med 1992; 327(11): 782–9
- Wood MJ, Johnson RW, McKendrick MW, et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330(13):896–900
- Esmann V, Geil JP, Kroon S, et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet 1987; 2(8551): 126–9
- Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39(7): 1546–53
- Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995; 123(2):89–96
- Straus SE. Sorrows, salves, and solutions. JAMA 1993; 269(14) 1836–9
- Safrin S, Berger TG, Gilson I. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella- zoster virus infection. Ann Intern Med 1991; 115(1):19–21
- Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45(RR-11):1–36